{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:26:54Z","timestamp":1782124014925,"version":"3.54.5"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T00:00:00Z","timestamp":1286755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>Pyridinium\u2010based oxime compounds have been utilized worldwide as antidotes following exposure to anticholinesterase agents. In the event of combined chemical and biological incident, it is of vital importance to know the ability of antidotes to provide additional protection against biological threats. This paper reports results of <jats:italic>in vitro<\/jats:italic> antimicrobial and antiprotozoal activities of a series of quaternary pyridinium oximes against a number of lower pathogenicity BSL\u20101 and 2 agents. In general, our compound panel had little to no antimicrobial action except for thiophene\u2010 and benzothiophene\u2010substituted monoquaternary pyridinium compounds <jats:bold>21<\/jats:bold> and <jats:bold>24<\/jats:bold> that showed moderate antibacterial activity against <jats:italic>Staphylococus aureus<\/jats:italic> and methicillin\u2010resistant <jats:italic>S.\u00a0aureus<\/jats:italic> with IC<jats:sub>50<\/jats:sub> values ranging from 12.2 to 17.7\u2003\u03bcg\/mL. Compounds <jats:bold>21<\/jats:bold> and <jats:bold>24<\/jats:bold> also exhibited antileishmanial activity against <jats:italic>Leishmania donovani<\/jats:italic> with IC<jats:sub>50<\/jats:sub> values of 19 and 18\u2003\u03bcg\/mL, respectively. Another monoquaternary pyridinium compound with a bromobutyl side chain <jats:bold>17<\/jats:bold> showed antimalarial activity against both a chloroquine sensitive and resistant strains of <jats:italic>Plasmodium falciparum<\/jats:italic> with IC<jats:sub>50<\/jats:sub> values of 3.7 and 4.0\u2003\u03bcg\/mL, respectively. None of the bisquaternary pyridinium compounds showed antimicrobial or antiprotozoal activity. None of the compounds showed cytotoxic effects toward mammalian kidney fibroblasts. Results of this study indicate that the pyridinium compounds, some of which are already in use as antidotes, do not have significant antimicrobial and antiprotozoal activities and cannot be relied upon for additional protection in the event of combined chemical\u2013biological incident.<\/jats:p>","DOI":"10.1111\/j.1747-0285.2010.01035.x","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T17:54:25Z","timestamp":1286819665000},"page":"546-551","source":"Crossref","is-referenced-by-count":18,"title":["Antimicrobial, Antimalarial, and Antileishmanial Activities of Mono\u2010 and Bis\u2010quaternary Pyridinium Compounds"],"prefix":"10.1111","volume":"76","author":[{"given":"Sandip B.","family":"Bharate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,11]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2423(04)38006-6"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120015840"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.5650\/jos.57.197"},{"key":"e_1_2_5_5_2","first-page":"177","article-title":"Synthesis and antimicrobial activities of some pyridinium salts","volume":"35","author":"Alptuzuun V.","year":"2006","journal-title":"Ankara Ecz Fak Derg"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11743-003-0254-5"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049106l"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00777632"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0223-5234(01)01226-0"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.2174\/1386207053328219"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.02.030"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.47.1020"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0704752"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.04.051"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9701886"},{"key":"e_1_2_5_16_2","first-page":"414","volume-title":"Small molecule DNA and RNA binders: from synthesis to nucleic acid complexes, Volume 2","author":"Tidwell R.R.","year":"2003"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0400092"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.797-807.2002"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/153537020422900409","article-title":"Fate of bioterrorism\u2010relevant viruses and bacteria, including spores, aerosolized into an indoor air environment","volume":"229","author":"Utrup L.J.","year":"2004","journal-title":"Exp Biol Med"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.07.035"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.11.052"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/np800653z"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(03)00538-0"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low\u2010technology MIC determination with clinical M. tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau S.G.","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1993.48.205"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4450-4452.2004"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5769(99)00020-3"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-004-1215-5"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(85)90118-6"},{"key":"e_1_2_5_30_2","first-page":"419","article-title":"Oral forms of the oxime HI\u20106: a study of the pharmacokinetics and tolerance after administration to healthy volunteers","volume":"32","author":"Jovanovic D.","year":"1990","journal-title":"Vet Hum Toxicol"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2008.02.017"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0285.2010.01035.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1747-0285.2010.01035.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:46:12Z","timestamp":1698713172000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1747-0285.2010.01035.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1747-0285.2010.01035.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1747-0285.2010.01035.x","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,11]]}}}